beta-Amyloid fragment 25-35 selectively decreases complex IV activity in isolated mitochondria

FEBS Lett. 1999 Aug 20;457(1):131-4. doi: 10.1016/s0014-5793(99)01028-5.

Abstract

Defects in mitochondrial oxidative metabolism, in particular decreased activity of cytochrome c oxidase, have been demonstrated in Alzheimer's disease, and after the expression of the amyloid precursor protein (APP) in cultured cells, suggesting that mitochondria might be involved in beta-amyloid toxicity. Recent evidence suggests that the proteolysis of APP to generate beta-amyloid is at least in part intracellular, preceding the deposition of extracellular fibrils. We have therefore investigated the effect of incubation of isolated rat brain mitochondria with the beta-amyloid fragment 25-35 (100 microM) on the activities of the mitochondrial respiratory chain complexes I, II-III, IV (cytochrome c oxidase) and citrate synthase. The peptide caused a rapid, dose-dependent decrease in the activity of complex IV, white it had no effect on the activities on any of the other enzymes tested. The reverse sequence peptide (35-25) had no effect on any of the activities measured. We conclude that inhibition of mitochondrial complex IV might be a contributing factor to the pathogenesis of Alzheimer's disease.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amyloid beta-Peptides / metabolism*
  • Amyloid beta-Peptides / physiology*
  • Animals
  • Brain / metabolism
  • Citrate (si)-Synthase / metabolism
  • Electron Transport / physiology
  • Electron Transport Complex IV / antagonists & inhibitors
  • Electron Transport Complex IV / metabolism*
  • Kinetics
  • Male
  • Mitochondria / metabolism*
  • Neurodegenerative Diseases / metabolism
  • Rats
  • Rats, Wistar
  • Time Factors

Substances

  • Amyloid beta-Peptides
  • Electron Transport Complex IV
  • Citrate (si)-Synthase